Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-26-031927

Chief Operating Officer gave up 1,944 shares (to pay taxes)

  • Chief Operating Officer acquired 4,384 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cittadine Andrew · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-30 Exercise or conversion : show line 1 in the form +4,384 59,998 D
2026-09-30 Shares withheld for taxes : show line 2 in the form −1,944 $79.67 $154,878 58,054 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-30 Exercise or conversion : show line 3 in the form Restricted Stock Unit −4,384 35,115 D
Loading xslF345X06/rdgdoc.xml…